当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第13期
编号:12832231
绝经后激素替代治疗对血清Lp(a)水平变化及其心血管系统的保护作用(3)
http://www.100md.com 2016年5月5日 《中国医学创新》 2016年第13期
     [8]张新华,张学兰,高峰,等.ET技术评价小剂量短期雌激素替代治疗绝经妇女颈动脉弹性[J].中国超声医学杂志,2012,28(1):78-81.

    [9]刘俊宝,刘晓军.绝经期雌激素替代治疗对血脂的影响[J].中国妇幼保健,2010,25(21):3014-3015.

    [10] Felix A S,Bunch K,Yang H P,et al.Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP diet and health study[J].Gynecologic Oncology Reports,2015,13(1):13-17.

    [11] Khafagy A M,Stewart K I,Christianson M S,et al.Effect of menopause hormone therapy on disease progression in systemic lupus erythematosus:A systematic review[J].Maturitas,2015,81(2):276-281.

    [12] Doty R L,Tourbier I,Ng V,et al.Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women[J].Neurobiology of Aging,2015,36(6):2053-2059.

    [13]李丽,玛依努尔·尼亚孜,鲍彦平,等.围绝经妇女激素替代治疗与妇科肿瘤关系的回顾分析[J].中国实用妇科与产科杂志,2010,25(11):849-852.

    [14] Hsieh K P,Chen L C,Cheung K L,et al.Risks of nonadherence to hormone therapy in Asian women with breast cancer[J].The Kaohsiung Journal of Medical Sciences,2015,31(6):328-334.

    [15] Mirkin S,Amadio J M,Bernick B A,et al.17β-estradiol and natural progesterone for menopausal hormone therapy:replenish phase 3 study design of a combination capsule and evidence review[J].Maturitas,2015,81(1):28-35.

    (收稿日期:2015-09-02) (本文编辑:李颖), http://www.100md.com(黄永申 彭冬先 黎涛)
上一页1 2 3